TargED Biopharmaceuticals
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | strategic, $2.7M, 2025-03-01attributed |
| Founded | unknown |
| Headquarters | Utrecht, Netherlands |
| Industry | unknown |
| Stage | series-b+ |
| Website | targedbiopharmaceuticals.com |
Thrombolytic nanobody therapy for blood clots
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-03-01 | strategic | $2.7M | undisclosed |
Detected tech stack
WordPress, Yoast SEO 27.6, Underscore.js 1.13.8, Font Awesome, jQuery Migrate 3.4.1, jsDelivr, Varnish, OpenResty, Nginx, PHP, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Strategic, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | targedbiopharmaceuticals.com, read 2026-05-08 |
| Description | self-reported | targedbiopharmaceuticals.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.